Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
57 hedge funds and large institutions have $31M invested in Ampio Pharmaceuticals Inc. in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
118% more call options, than puts
Call options by funds: $1.7M | Put options by funds: $780K
24% more capital invested
Capital invested by funds: $25M → $31M (+$6M)
12% more funds holding
Funds holding: 51 → 57 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$629K |
| 2 |
FPCP
Fort Point Capital Partners
San Francisco,
California
|
+$306K |
| 3 |
BCM
Bluefin Capital Management
New York
|
+$189K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$158K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$126K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$442K |
| 2 |
Goldman Sachs
New York
|
-$295K |
| 3 |
Morgan Stanley
New York
|
-$113K |
| 4 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$107K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$61.4K |
AMPE Hedge Fund Activity: Q4 2015 in Review
57 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2015, worth a combined $31M — up 24% from $25M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new AMPE positions and 3 closed out — a net gain of 6 holders — while 9 added to existing stakes and 12 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $629K. The largest seller was Millennium Management, cutting an estimated $442K.
- 57 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2015, up from 51 in Q3 2015.
- Funds reported $31M of Ampio Pharmaceuticals Inc. stock for Q4 2015, up 24% quarter-over-quarter.
- 9 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2015 and 3 closed out, a net change of +6 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2015 was Susquehanna International Group, an estimated $629K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2015 was Millennium Management, an estimated $442K sold.
Based on aggregated 13F filings for Q4 2015.